Wells Fargo analyst Stephen Baxter raised the firm’s price target on McKesson (MCK) to $766 from $691 and keeps an Equal Weight rating on the shares. The firm is updating its model following Q4 earnings and fiscal 2026 guide. Wells remains on the sidelines given premium vs. peers required despite what it sees as more exposure to overhangs.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
- McKesson Issues $2 Billion Notes for Acquisition
- Sector Spotlight: Trump executive order targets drug prices
- McKesson’s Strategic Positioning and Growth Potential: Buy Rating with $800 Price Objective
- Strategic Spin-Off and Strong Core Businesses Drive McKesson’s Buy Rating
- Trump’s drug-price crackdown may lead to minor concessions, WSJ reports
